Drug Type Small molecule drug |
Synonyms 17-Alpha estradiol, 17-α estradiol, 17alpha-Estradiol + [6] |
Target |
Action agonists |
Mechanism ERs agonists(Estrogen receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC18H24O2 |
InChIKeyVOXZDWNPVJITMN-SFFUCWETSA-N |
CAS Registry57-91-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07121 | Alfatradiol |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Alopecia | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 2 | United States | - | - |
Friedreich Ataxia | Phase 2 | United States | - | - |
Parkinson Disease | Phase 2 | United States | - | - |
Retinitis Pigmentosa | Phase 2 | United States | - |
Phase 4 | 35 | wfhhmbeggg(bxskhewitd) = tawklfrcll uaqpsfclzx (qgielqpnql, xmvvikozcn - sacvictdks) View more | - | 23 Sep 2021 |